| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/05/2006 | US20060222629 Compositions and methods for delivery of genetic material |
| 10/05/2006 | US20060222628 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses |
| 10/05/2006 | US20060222627 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| 10/05/2006 | US20060222623 Composition for treating dry eye and related methods of manufacture and methods of use |
| 10/05/2006 | US20060222622 Methods and compositions for preventing and treating radiation-induced skin reactions |
| 10/05/2006 | US20060222620 Composition for pharmaceutical or dietetic use for combating hair loss |
| 10/05/2006 | US20060222611 Lip balm |
| 10/05/2006 | US20060222603 Compositions having anti-dental caries function |
| 10/05/2006 | US20060222599 Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine |
| 10/05/2006 | US20060222598 Scopine 2,2-diphenylpropionate-metho halides and other salts: propellant-free solution with ethanol and water and an acid; optimum nebulization; storage stability; nebulizer |
| 10/05/2006 | US20060222597 Buccal, polar and non-polar sprays containing propofol |
| 10/05/2006 | US20060219242 Method for the Administration of an Anticholinergic by Inhalation |
| 10/05/2006 | DE202005020766U1 Neue Kristallformen von Atorvastatin-Hemi-Calcium New crystal forms of atorvastatin hemi-calcium |
| 10/05/2006 | DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 10/05/2006 | DE112004002032T5 Concentricolid und seine Derivate, Verfahren zum Herstellen pharmazeutischer Zusammensetzungen umfassend deren Verwendung Concentricolid and its derivatives, method for preparing pharmaceutical compositions comprising the use of |
| 10/05/2006 | DE102005015957A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders |
| 10/05/2006 | DE102005015253A1 New pyrazole derivatives are tyrosine kinase inhibitors useful to treat e.g. solid tumors, diabetic retinopathy, age-related macular degeneration or inflammatory disease, osteoarthritis and rickets |
| 10/05/2006 | DE102005015128A1 Wafer enthaltend Steroidhormone Wafer containing steroid hormones |
| 10/05/2006 | DE102005015040A1 Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 10/05/2006 | DE102005014370A1 Topical product, for the prevention and treatment of diaper dermatitis, contains betaine |
| 10/05/2006 | DE102005014248A1 Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid A pharmaceutical preparation of N- [5- (aminosulfonyl) -4-methyl-1,3-thiazol-2-yl] -N-methyl-2- [4- (2-pyridinyl) phenyl] acetamide |
| 10/05/2006 | DE102005014245A1 Antibakterielle Amid-Makrozyklen V Antibacterial amide macrocycles V |
| 10/05/2006 | DE102005014142A1 Pelletförmige Retardzubereitung gegen Schwindel Delayed-release pellet shaped against scams |
| 10/05/2006 | DE102005013967A1 New imidazole or pyrimidine derivatives are bradykinin B1 antagonists used for treating e.g. pain, stroke, peptic ulcers and other inflammatory disorders |
| 10/05/2006 | DE102005013380A1 Extraktionsverfahren Extraction method |
| 10/05/2006 | DE102005001784A1 Double strand molecule oligoribonucleotide/salt to induce dismantling of mRNA for cellular synthesis, and to transport neurotransmitter acetyl chlorine is used for reduction of sweat secretion |
| 10/05/2006 | DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments |
| 10/05/2006 | CA2610854A1 Nicotinamide riboside and analogues thereof |
| 10/05/2006 | CA2610502A1 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| 10/05/2006 | CA2605121A1 Dermatological compositions and salts for the treatment of dermatological diseases |
| 10/05/2006 | CA2604352A1 Garlic extract and chitosan compositions, and uses thereof |
| 10/05/2006 | CA2603683A1 Treatment of epilepsy with non-imidazole alkylamines histamine h3-receptor ligands |
| 10/05/2006 | CA2603656A1 Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/05/2006 | CA2603450A1 Compositions for oral transmucosal delivery of metformin |
| 10/05/2006 | CA2603371A1 Trihydroxy polyunsaturated eicosanoid derivatives |
| 10/05/2006 | CA2603360A1 Piperazinyl substituted cyclohexane 1,4-diamines |
| 10/05/2006 | CA2603345A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 10/05/2006 | CA2603334A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 10/05/2006 | CA2603328A1 2-methylene-19-nor-(23s)-25-dehydro-1.alpha.-hydroxyvitamin d3-26,23-lactone and 2-methylene-19-nor-(23r)-25-dehydro-1.alpha.-hydroxyvitamin d3-26,23-lactone |
| 10/05/2006 | CA2603322A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | CA2603316A1 Combined-step process for pharmaceutical compositions |
| 10/05/2006 | CA2603300A1 Oxaprozin or a closely related compound for the treatment of eczema |
| 10/05/2006 | CA2603297A1 Oxaprozin or closely related compound for the treatment and prevention of |
| 10/05/2006 | CA2603235A1 Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
| 10/05/2006 | CA2603191A1 Cancer vaccines and therapeutic methods |
| 10/05/2006 | CA2603163A1 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
| 10/05/2006 | CA2603126A1 Spirocyclic heterocyclic derivatives and methods of their use |
| 10/05/2006 | CA2603125A1 Thienopyridine derivative, quinoline derivatives,and quinazoline derivatives, having c-met autophosphorylation inhibiting activity |
| 10/05/2006 | CA2603122A1 Phenyl and pyridyl lta4h modulators |
| 10/05/2006 | CA2603088A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | CA2603049A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 10/05/2006 | CA2603041A1 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 10/05/2006 | CA2603009A1 Treatment of eye disorders with sirtuin modulators |
| 10/05/2006 | CA2602832A1 Low-concentration capsaicin patch and methods for treating neuropathic pain |
| 10/05/2006 | CA2602750A1 Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide |
| 10/05/2006 | CA2602691A1 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
| 10/05/2006 | CA2602641A1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
| 10/05/2006 | CA2602576A1 Prokineticin 1 receptor antagonists |
| 10/05/2006 | CA2602574A1 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | CA2602566A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 10/05/2006 | CA2602563A1 Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 10/05/2006 | CA2602562A1 Modulation of telomere length in telomerase positive cells and cancer therapy |
| 10/05/2006 | CA2602553A1 2,4,8-trisubstituted 8h-pyrido[2,3-d]pyrimidin-7-one derivatives, compositions thereof, and uses thereof |
| 10/05/2006 | CA2602546A1 Novel compounds |
| 10/05/2006 | CA2602538A1 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 10/05/2006 | CA2602533A1 Use of c-nucleoside analogs for treatment of hepatitis c related viral infections |
| 10/05/2006 | CA2602510A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | CA2602386A1 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor |
| 10/05/2006 | CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | CA2602284A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | CA2602257A1 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 10/05/2006 | CA2602254A1 Pharmacokinetically improved compounds |
| 10/05/2006 | CA2602250A1 Pyridine derivatives useful as inhibitors of pkc-theta |
| 10/05/2006 | CA2602227A1 4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 10/05/2006 | CA2602223A1 New class of yo t cells activators and use thereof |
| 10/05/2006 | CA2602110A1 Morinda citrifolia based antifungal formulations and methods |
| 10/05/2006 | CA2602075A1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 10/05/2006 | CA2601898A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 10/05/2006 | CA2601794A1 Methods of treatment utilizing certain melatonin derivatives |
| 10/05/2006 | CA2601702A1 2, 4, 5-substituted piperidines as renin inhibitors |
| 10/05/2006 | CA2601699A1 Substituted piperidines |
| 10/05/2006 | CA2601575A1 Spirocyclic thrombin receptor antagonists |
| 10/05/2006 | CA2601126A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
| 10/05/2006 | CA2601108A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | CA2600833A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 10/05/2006 | CA2600791A1 Inhibitors of neurotrypsin and determination thereof |
| 10/05/2006 | CA2600386A1 Indoloquinone tumor radiation sensitization |
| 10/05/2006 | CA2600374A1 Novel carbapenem compound |
| 10/05/2006 | CA2599384A1 New pharmaceutical compositions useful in the treatment of parkinson's disease |
| 10/05/2006 | CA2598892A1 Tablet containing steroid hormones |
| 10/05/2006 | CA2598878A1 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors |
| 10/05/2006 | CA2582230A1 A novel process for preparation of substantially pure glimepiride |
| 10/05/2006 | CA2504447A1 Diet food product |
| 10/05/2006 | CA2504439A1 External preparation for improving blood flow |
| 10/05/2006 | CA2503945A1 Composition for regulating bone metabolism |
| 10/05/2006 | CA2503746A1 Methods for treating urinary incontinence and other disorders using trospium |
| 10/04/2006 | EP1707633A1 Alphavirus vectors for paramyxovirus vaccines |
| 10/04/2006 | EP1707630A1 Antisense oligonucleotide having anticancerous activity |
| 10/04/2006 | EP1707622A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof |